規格 | 目錄價格 | 上海 | 安徽 | 武漢 | 成都 | 北方 | 深圳 | 會員價格 | 數量 |
---|---|---|---|---|---|---|---|---|---|
5g | ¥ ????? | > 10 | > 10 | -- | -- | 1 | -- | ¥ ????? | - + |
10g | ¥ ?????? | > 10 | 6 | 1 | -- | -- | -- | ¥ ?????? | - + |
25g | ¥ ?????? | 6 | 2 | 1 | 2 | 3 | 2 | ¥ ?????? | - + |
100g | ¥ ?????? | 1 | -- | -- | -- | 1 | 1 | ¥ ?????? | - + |
500g | ¥ ??ǖ???? | -- | -- | -- | -- | -- | -- | ¥ ??ǖ???? | - + |
1000g | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
大貨 | 請詢價 | -- | -- | -- | -- | -- | -- | -- | - + |
產品編號
1032010
CAS 號
402-61-9
中文名稱
3-甲基-1H-吡唑-5-甲酸
MDL 號
MFCD00090754
分子量
126.11
存儲條件
2-8°C
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
241°C
沸點
388.8°C at 760 mmHg
閃點
旋光
描述
TPSA
65.98
LogP
0.41632
H_Acceptors
2
H_Donors
2
Rotatable_Bonds
1
[1]. Adage T, et al. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.?Eur Neuropsychopharmacol. 2008;18(3):200-214.
[2]. D D Myles, et al. The development of tolerance to antilipolytic agents in rats. Biochem Pharmacol. 1985 Jan 15;34(2):269-74.
[3]. G D Stratton, et al. The development of tolerance to antilipolytic agents by isolated rat adipocytes. Biochem Pharmacol. 1985 Jan 15;34(2):275-9.
[4]. K Credner, et al. [Salts of 5-methylpyrazole-3-carboxylic acid with basically substituted adenine derivatives. Identification and lipolysis inhibitory activity (author's transl)]. Arzneimittelforschung. 1981;31(12):2096-100.
[5]. Kana Ishii, et al. Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers. Chirality. 2010 Nov;22(10):901-6.
警示圖
警示詞
Warning
危險申明
H302-H315-H319-H335
警告申明
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
GHS 編碼
GHS07
展開更多
現貨供應
專業護航
售后無憂
品質保障
無需湊單